Garcinia cambogia Garcinia gummi-gutta (L.) N.Robson
Also called: Garcinia cambogia Desr. (illegitimate synonym), Malabar tamarind, brindle berry, hydroxycitric acid (HCA)
Garcinia gummi-gutta, sold as Garcinia cambogia and also called Malabar tamarind, is a tree native to western India. Its dried fruit rind is a sour spice and food preservative; extracts containing hydroxycitric acid (HCA) are marketed for appetite control and weight loss.
- Category
- Botanical
- Part used
- Fruit rind (peel); extracts standardized to hydroxycitric acid
- Strongest evidence
- B Some positive trials
- Native range
- Native to western India (POWO: "W. India")
- Reviewed
- 2026-10-30
Class 1 Well studied in people. A 2011 systematic review included 12 RCTs (706 participants) of Garcinia extract/hydroxycitric acid alone, excluding trials of combination products, and pooled nine in meta-analysis. [3]
Fact-checked 2026-10-30 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
BHeart and blood vessels1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Body weight in adults (2011 meta-analysis) | B | A 2011 systematic review included 12 RCTs and pooled nine: a small, statistically significant weight loss versus placebo (-0.88 kg, 95% CI -1.75 to -0.00); clinical relevance was uncertain. [3] |
| Body weight in adults with obesity (12-week trial) | C | In a 12-week placebo-controlled trial cited by LiverTox, 135 adults with obesity given HCA 1,500 mg daily lost a similar amount of weight as those on placebo (3.2 vs 4.1 kg). [1] |
| Weight, BMI, body fat and waist (2020 meta-analysis) | B | A 2020 meta-analysis of eight RCTs (530 subjects) found lower weight (-1.34 kg), BMI (-0.99 kg/m2), percentage fat mass (-0.42%) and waist circumference (-4.16 cm) than placebo. [4] |
| Weight loss overall (NCCIH assessment) | C | NCCIH states it is unclear whether Garcinia cambogia products help with weight loss: some evidence suggests a modest effect, while other evidence shows none. [2] |
| Blood lipids | B | A 2024 meta-analysis of 14 trials (623 subjects) found lower total cholesterol (-6.76 mg/dL) and triglycerides (-24.21 mg/dL) and higher HDL (+2.95 mg/dL); LDL was not significantly affected, and heterogeneity was significant. [5] |
| Fasting glucose, insulin and liver enzymes | C | A 2025 meta-analysis of nine publications (444 participants) found no significant effect on fasting blood sugar, insulin, ALT or AST compared with control groups. [6] |
Main constituents: Hydroxycitric acid (HCA), the suspected active component: Garcinia fruit is 10% to 30% HCA by weight and extracts contain 20% to 60%; HCA inhibits ATP citrate lyase, an enzyme of fatty acid synthesis [1]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- HCA 1,500 mg daily for 12 weeks (trial in 135 adults with obesity). [1]
- Health Canada monograph (September 26, 2025), adults: 2–3 g per day of extract standardized to 50–60% hydroxycitric acid, 1.5–2 g per single dose, taken before meals; consult a practitioner for use beyond 12 weeks. [7]
No official upper intake level has been set.
Safety and side effects
- Liver (NIH LiverTox)Score BABCDEA: well known causeE: unlikely cause
LiverTox likelihood score B: likely rare cause of clinically apparent liver injury (chapter last updated February 13, 2019).
Details and sources - Pregnancy and breastfeedingHealth Canada monograph: "Do not use if you are pregnant"; consult a practitioner before use if breastfeeding.
2 statements in the profile.
Details and sources - Interactions with medicines2 listed
Drugs that affect the liver; Drugs that affect serotonin
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notifications10 on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsStated
Health Canada NNHPD Malabar tamarind monograph (September 26, 2025), adults 18 and older: 2–3 g per day of fruit-peel extract standardized to 50–60% …
Details and sources
- Liver injury: LiverTox likelihood score B, a likely rare cause of clinically apparent liver injury (chapter updated February 13, 2019). At least a dozen reports involve multi-ingredient products containing Garcinia (some, such as Hydroxycut, also contained other suspected hepatotoxins); more recent cases involved products labeled as Garcinia alone. [1]
- LiverTox: injury typically appears 1 to 4 weeks after starting (some cases 3 to 12 months), is hepatocellular, and ranges from enzyme elevations to acute liver failure; some cases led to death or urgent liver transplantation. Rechallenge should be avoided. [1]
- NCCIH: it may be unsafe to consume these products, including multi-ingredient products containing the extract; several cases of liver damage, some severe, have been reported, though this appears uncommon. [2]
- NCCIH: other side effects include headache, nausea, diarrhea and other gastrointestinal symptoms. [2]
- Health Canada's monograph states "Do not use if you are pregnant" and requires consulting a practitioner before use if breastfeeding, with a liver disorder, or when taking medications; stop use if yellowing of the eyes or skin, dark urine, nausea, vomiting or stomach pain occur. [7]
Interactions
| With | What happens |
|---|---|
| Drugs that affect the liver | NCCIH: interactions have been reported with some drugs that affect the liver. [2] |
| Drugs that affect serotonin | NCCIH: interactions have been reported with some drugs that affect serotonin. [2] |
Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.
Identity, quality and standardization
Regulatory status
- US: products with HCA are marketed as dietary supplements, which are not approved by the FDA before sale; manufacturers are responsible for evaluating their safety and labeling (NCCIH). [2]
- Canada: Health Canada NNHPD Malabar tamarind (Garcinia gummi-gutta) fruit-peel monograph (September 26, 2025) permits the claim "Could help temporarily increase satiety/feeling of fullness". [7]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
- Hydroxycitric acid (HCA), suspected active component; fruit 10% to 30% HCA by weight, extracts 20% to 60% Organic acid (LiverTox: a tricarboxylic acid) [P1]
US status
What FDA's published records show. FDA does not approve dietary supplements.
- FDA's published NDI notification list has 10 entries naming Garcinia cambogia or (-)-hydroxycitric acid (earliest NDI 41 submitted 1998-11-03; most recent NDI 359 submitted 2005-10-27). Each notification covers one firm's specific ingredient and conditions of use; the list does not state FDA's response. [P6]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
- No IARC or NTP carcinogenicity evaluation of Garcinia cambogia (Garcinia gummi-gutta) or hydroxycitric acid was found (IARC Monographs list of classifications, Volumes 1–142, and NTP technical reports checked 2026-10-29). [P7]
- The NTP Technical Reports index (TR-001 to TR-606) lists no study of Garcinia or hydroxycitric acid (checked 2026-10-29). [P8]
Liver (NIH LiverTox)
- LiverTox likelihood score B: likely rare cause of clinically apparent liver injury (chapter last updated February 13, 2019). Onset typically 1 to 4 weeks (sometimes 3 to 12 months) after starting; hepatocellular pattern; severity from enzyme elevations to acute liver failure, with some deaths or urgent liver transplants; frequency not known but likely uncommon (less than 1:10,000 persons). Most reported cases involved multi-ingredient products, some (such as Hydroxycut) also containing other suspected hepatotoxins; more recent cases involved products labeled as Garcinia cambogia alone. [P1]
Interactions with medicines
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- LiverTox lists mislabeling or adulteration as a possible explanation for liver injury cases, and notes that several implicated multi-ingredient products also contained other suspected hepatotoxins. [P1]
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity: at least one appropriate test or examination to verify the identity of each component that is a dietary ingredient (21 CFR 111.75(a)(1)(i)) — General Part 111 requirement for every dietary ingredient; a firm may petition FDA for an exemption under 111.75(a)(1)(ii). [P9]
- Hydroxycitric acid content assay — Health Canada's monograph defines the dose as extract standardized to 50–60% hydroxycitric acid. [P3]
Supply and conservation
- IUCN Red List: Least Concern (LC), via GBIF species API, retrieved 2026-10-29. [P10]
Absorption in people
- In four people given 2 g of HCA, plasma HCA ranged from 0.8 to 8.4 µg/mL at 30 minutes and 2 hours after ingestion; the authors concluded HCA is absorbed but present in small quantities. [P4]
- In a phase I crossover study in healthy women (1,500 mg extract providing 750 mg HCA), a high-calorie breakfast lowered HCA Cmax 3-fold and AUC0-10h 2-fold versus fasting, with large inter-individual variation. [P5]
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- Health Canada NNHPD Malabar tamarind monograph (September 26, 2025), adults 18 and older: 2–3 g per day of fruit-peel extract standardized to 50–60% hydroxycitric acid, 1.5–2 g per single dose, before meals; consult a practitioner for use beyond 12 weeks. [P3]
Sources for this profile
- NIH LiverTox (NIDDK). Garcinia Cambogia (Last Update: February 13, 2019), 2019-02-13. ncbi.nlm.nih.gov
- NCCIH. Garcinia Cambogia: Usefulness and Safety (Last Updated: February 2025), 2025-02. nccih.nih.gov
- Health Canada, NNHPD. Monograph: Malabar tamarind - Garcinia gummi-gutta (dated September 26, 2025), 2025-09-26. webprod.hc-sc.gc.ca
- Loe YC, et al. Gas chromatography/mass spectrometry method to quantify blood hydroxycitrate concentration. Anal Biochem 2001;292(1):148-154 (PMID 11319829), 2001-05. pubmed.ncbi.nlm.nih.gov
- Cruz AC, et al. Food-effect on (-)-hydroxycitric acid absorption after oral administration of Garcinia cambogia extract formulation: a phase I, randomized, cross-over study. J Pharm Sci 2021;110(2):693-697 (PMID 33164784), 2021-02. pubmed.ncbi.nlm.nih.gov
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- IARC Monographs. List of Classifications, Volumes 1–142 (retrieved 2026-10-29), 2026-10-29. monographs.iarc.who.int
- National Toxicology Program. Technical Reports (TR series index, TR-001 to TR-606; retrieved 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
- eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
- GBIF species API: IUCN Red List category for Garcinia gummi-gutta (L.) N.Robson, 2026-10-29. api.gbif.org
Sources
- NIH LiverTox (NIDDK). Garcinia Cambogia (Last Update: February 13, 2019), 2019-02-13. ncbi.nlm.nih.gov
- NCCIH. Garcinia Cambogia: Usefulness and Safety (Last Updated: February 2025), 2025-02. nccih.nih.gov
- Onakpoya I, et al. The use of Garcinia extract (hydroxycitric acid) as a weight loss supplement: a systematic review and meta-analysis of randomised clinical trials. J Obes 2011;2011:509038 (PMID 21197150), 2010-12-14. pubmed.ncbi.nlm.nih.gov
- Golzarand M, Omidian M, Toolabi K. Effect of Garcinia cambogia supplement on obesity indices: a systematic review and dose-response meta-analysis. Complement Ther Med 2020;52:102451 (PMID 32951714), 2020-08. pubmed.ncbi.nlm.nih.gov
- Amini MR, et al. The effects of Garcinia cambogia (hydroxycitric acid) on lipid profile: a systematic review and meta-analysis of randomized controlled trials. Phytother Res 2024;38(2):1028-1043 (PMID 38151892), 2024-02. pubmed.ncbi.nlm.nih.gov
- Tavakoli S, et al. The effects of Garcinia cambogia on glycaemic control and liver enzymes in adults: a systematic review and meta-analysis of randomised controlled trials. J Nutr Sci 2025;14:e8 (PMID 39943939), 2025-01. pubmed.ncbi.nlm.nih.gov
- Health Canada, NNHPD. Monograph: Malabar tamarind - Garcinia gummi-gutta (dated September 26, 2025), 2025-09-26. webprod.hc-sc.gc.ca
- Plants of the World Online (POWO), Royal Botanic Gardens, Kew; WCVP data. Garcinia gummi-gutta (L.) N.Robson; synonyms include Garcinia cambogia Desr. (nom. illeg. superfl.) (accessed 2026-10-29; native range: "W. India"), 2026-10-29. powo.science.kew.org
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.